Anhui Huaertai Chemical Co., Ltd. (SHE:001217)
14.70
-0.85 (-5.47%)
At close: Feb 13, 2026
Anhui Huaertai Chemical Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 |
Operating Revenue | 1,941 | 1,626 | 1,776 | 2,089 | 1,887 | 1,138 |
Other Revenue | 15.14 | 15.14 | 15.72 | 12.33 | 6.84 | 9.77 |
| 1,956 | 1,641 | 1,792 | 2,101 | 1,894 | 1,148 | |
Revenue Growth (YoY) | 16.09% | -8.42% | -14.73% | 10.97% | 65.02% | -8.70% |
Cost of Revenue | 1,804 | 1,428 | 1,507 | 1,755 | 1,289 | 881.44 |
Gross Profit | 152.23 | 213.37 | 284.95 | 346.64 | 605.06 | 266.11 |
Selling, General & Admin | 68.65 | 77.08 | 62.61 | 57.97 | 63.84 | 38 |
Research & Development | 54.66 | 49.6 | 55.5 | 64.48 | 60.25 | 41.11 |
Other Operating Expenses | -5.87 | -1.93 | -0.65 | 12.87 | 13.63 | 11.63 |
Operating Expenses | 117.61 | 124.49 | 116.92 | 135.09 | 139.03 | 91.22 |
Operating Income | 34.62 | 88.88 | 168.03 | 211.55 | 466.03 | 174.9 |
Interest Expense | -1.62 | -1.62 | -0 | - | -0.58 | -1.43 |
Interest & Investment Income | 5.65 | 4.45 | 19.04 | 17.49 | 2.08 | 0.12 |
Currency Exchange Gain (Loss) | 0.11 | 0.11 | 0.08 | -0.34 | 0.04 | - |
Other Non Operating Income (Expenses) | 2.54 | -0.36 | -0.5 | -0.85 | -0.17 | -0.03 |
EBT Excluding Unusual Items | 41.3 | 91.47 | 186.66 | 227.85 | 467.39 | 173.55 |
Gain (Loss) on Sale of Investments | -4.4 | 1.15 | -2.98 | 8.19 | 1 | -0.04 |
Gain (Loss) on Sale of Assets | - | - | 0.03 | -2.07 | - | - |
Asset Writedown | 1 | -0.63 | -6.57 | -0.86 | -0.89 | -0.95 |
Other Unusual Items | 7.38 | 7.38 | 4.3 | 19.49 | 14.49 | 20.91 |
Pretax Income | 45.29 | 99.37 | 181.43 | 252.59 | 482 | 193.47 |
Income Tax Expense | 15.83 | 11.63 | 23.16 | 32.83 | 66.41 | 25.53 |
Net Income | 29.45 | 87.74 | 158.28 | 219.77 | 415.59 | 167.95 |
Net Income to Common | 29.45 | 87.74 | 158.28 | 219.77 | 415.59 | 167.95 |
Net Income Growth | -78.78% | -44.56% | -27.98% | -47.12% | 147.45% | 14.92% |
Shares Outstanding (Basic) | 322 | 337 | 330 | 333 | 270 | 251 |
Shares Outstanding (Diluted) | 322 | 337 | 330 | 333 | 270 | 251 |
Shares Change (YoY) | -2.75% | 2.34% | -0.97% | 23.39% | 7.66% | 1.20% |
EPS (Basic) | 0.09 | 0.26 | 0.48 | 0.66 | 1.54 | 0.67 |
EPS (Diluted) | 0.09 | 0.26 | 0.48 | 0.66 | 1.54 | 0.67 |
EPS Growth | -78.18% | -45.83% | -27.27% | -57.14% | 129.85% | 13.56% |
Free Cash Flow | -214.62 | -146.97 | -344 | -107.05 | 256.93 | 98 |
Free Cash Flow Per Share | -0.67 | -0.44 | -1.04 | -0.32 | 0.95 | 0.39 |
Dividend Per Share | 0.100 | 0.100 | 0.100 | 0.100 | 0.300 | - |
Dividend Growth | - | - | - | -66.67% | - | - |
Gross Margin | 7.78% | 13.00% | 15.90% | 16.50% | 31.95% | 23.19% |
Operating Margin | 1.77% | 5.42% | 9.38% | 10.07% | 24.61% | 15.24% |
Profit Margin | 1.51% | 5.35% | 8.83% | 10.46% | 21.95% | 14.64% |
Free Cash Flow Margin | -10.97% | -8.96% | -19.20% | -5.09% | 13.57% | 8.54% |
EBITDA | 154.53 | 207.46 | 284.82 | 319.28 | 548.04 | 250.05 |
EBITDA Margin | 7.90% | 12.64% | 15.90% | 15.19% | 28.94% | 21.79% |
D&A For EBITDA | 119.91 | 118.57 | 116.79 | 107.73 | 82.01 | 75.16 |
EBIT | 34.62 | 88.88 | 168.03 | 211.55 | 466.03 | 174.9 |
EBIT Margin | 1.77% | 5.42% | 9.38% | 10.07% | 24.61% | 15.24% |
Effective Tax Rate | 34.96% | 11.71% | 12.76% | 13.00% | 13.78% | 13.19% |
Revenue as Reported | 1,956 | 1,641 | 1,792 | 2,101 | 1,894 | 1,148 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.